Airain Ltd’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
– Sell
-37,586
Closed -$138K – 1090
2017
Q1
$138K Sell
37,586
-532
-1% -$2.25K 0.01% 739
2016
Q4
$184K Buy
+38,118
New +$1.13M 0.01% 607
2015
Q1
– Sell
-22,446
Closed -$1.01M – 1001
2014
Q4
$1.01M Buy
22,446
+10,264
+84% +$431K 0.08% 275
2014
Q3
$474K Sell
12,182
-10,486
-46% -$412K 0.03% 460
2014
Q2
$959K Buy
+22,668
New +$832K 0.08% 272

Other funds holding ISEE

Airain Ltd's ISEE Position: Q2 2017 in Review

Airain Ltd sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2017, closing a stake of 37,586 shares — an estimated $138K sold.

Airain Ltd first reported a position in ISEE in Q2 2014 and held it in 5 quarters. The position peaked at $1.01M in Q4 2014. 77 funds tracked by Wall St. Rank hold ISEE as of Q2 2017.

  • Airain Ltd reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • Airain Ltd sold 37,586 IVERIC bio, Inc. Common Stock shares in Q2 2017, an estimated $138K.
  • Airain Ltd first reported a position in IVERIC bio, Inc. Common Stock in Q2 2014 and held it in 5 quarters.
  • Airain Ltd's IVERIC bio, Inc. Common Stock position peaked at $1.01M in Q4 2014.
  • 77 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.